Seeds, Silk, and Solar: Innovation-Led Rally Sparks Morning Momentum

DENVER, Colo., Oct 15, 2025 (247marketnews.com)- Agritech stocks are sprouting gains this morning, fueled by geopolitical tension and domestic innovation. Origin Agritech (NASDAQ:SEED) is rallying after its triumphant return to Northeast China, where its September showcase of next-gen corn hybrids drew over 200 dealers. The company also inked a strategic partnership with Fengtian Seed Industry, introduced disease-resistant, high-yield varieties like Jinqiao 8, and highlighted gene-editing advances with China Agricultural University. With U.S.-China trade rhetoric heating up, ironically, the backdrop is strengthening investor focus on food security and biotech self-reliance. CEO Weibin Yan called the regional re-entry “pivotal,” and analysts are eyeing 2026 revenue upside.

Elsewhere in next-gen bio-materials, Kraig Biocraft Laboratories (OTCQB:KBLB) recently debuted BAM 1 Alpha, a genetically enhanced spider silk spinning silkworm hybrid that delivers a 245% increase in hybrid vigor. This breakthrough could mark a turning point in commercializing spider silk, with defense and industrial textile applications on the horizon.

Genprex (NASDAQ:GNPX) is also seeing strength as collaborators prepare to present positive preclinical data for Reqorsa Gene Therapy in ALK-positive lung cancer at the upcoming AACR-NCI-EORTC conference. CEO Ryan Confer noted the data further validate Reqorsa as a potential treatment for tough-to-treat cancer subsets.

Meanwhile, cleantech and energy are charging forward. Dragonfly Energy (NASDAQ:DFLI) just secured a U.S. patent for its Dragonfly IntelLigence battery mesh network, advancing smart lithium energy storage.

Nextracker (NASDAQ:NXT) and T1 Energy (NYSE:TE) signed a multi-year, $75M+ deal to domestically manufacture solar panel frames using U.S.-sourced steel—a direct reshoring play amid AI-driven energy demand.

Also making waves, SciSparc (NASDAQ:SPRC) announced a reverse takeover of Miza III Ventures (TSXV:MIZA.P), consolidating its pharma and nutraceutical assets in a newly renamed NeuroThera Labs Inc., giving the company 75–84% post-deal control. As innovation dominates headlines across sectors, markets are opening with strong speculative energy—and a growing appetite for disruptive narratives.

For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com

Please click here to read the full Kraig Labs analyst report on 247marketnews.com.

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (KBLB, SEED, GNPX, DFLI, NXT, TE)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.